Methyl 6-morpholinonicotinate is a chemical compound characterized by its unique structure, which combines a nicotinic acid derivative with a morpholine moiety. This compound typically appears as a white to off-white solid and is soluble in polar organic solvents. It features a methyl ester functional group, which contributes to its reactivity and potential applications in medicinal chemistry. The morpholine ring enhances its pharmacological properties, making it of interest in drug development, particularly for its potential effects on the central nervous system. Methyl 6-morpholinonicotinate may exhibit various biological activities, including anti-inflammatory and neuroprotective effects, although specific biological data may vary. As with many organic compounds, handling should be done with care, considering safety data sheets for toxicity and environmental impact. Overall, this compound represents a valuable scaffold in the synthesis of novel therapeutic agents, reflecting the ongoing interest in derivatives of nicotinic acid in pharmaceutical research.

methyl 6-morpholinonicotinate

132546-81-7: Methyl 6-morpholinonicotinate is a chemical compound characterized by its unique structure, which combines a nicotinic acid derivative with a morpholine moiety. This compound typically appears as a white to off-white solid and is soluble in polar organic solvents. It features a methyl ester functional group, which contributes to its reactivity and potential applications in medicinal chemistry. The morpholine ring enhances its pharmacological properties, making it of interest in drug development, particularly for its potential effects on the central nervous system. Methyl 6-morpholinonicotinate may exhibit various biological activities, including anti-inflammatory and neuroprotective effects, although specific biological data may vary. As with many organic compounds, handling should be done with care, considering safety data sheets for toxicity and environmental impact. Overall, this compound represents a valuable scaffold in the synthesis of novel therapeutic agents, reflecting the ongoing interest in derivatives of nicotinic acid in pharmaceutical research.

CAS 132546-81-7

methyl 6-morpholinonicotinate

3-Pyridinecarboxylic acid, 6-(4-morpholinyl)-, methyl ester

Ref: IN-DA0010TE

methyl 6-morpholinonicotinate

Ref: 54-OR23276

Methyl 6-morpholinonicotinate

Ref: 10-F635965